Alprazolam Tablet, Extended Release
NDC Package 63187-518-90
Package Information
Alprazolam tablets is alprazolam extended-release tablets USP are indicated for the treatment of panic disorder, with or without agoraphobia.This claim is supported on the basis of two positive studies with alprazolam extended-release tablets USP conducted in patients whose diagnoses corresponded closely to the DSM-III-R/IV criteria for panic disorder (see CLINICAL EFFICACY TRIALS).Panic disorder (DSM-IV) is characterized by recurrent unexpected panic attacks, i.e., a discrete period of intense fear or discomfort in which four (or more) of the following symptoms develop abruptly and reach a peak within 10 minutes: (1) palpitations, pounding heart, or accelerated heart rate; (2) sweating; (3) trembling or shaking; (4) sensations of shortness of breath or smothering; (5) feeling of choking; (6) chest pain or discomfort; (7) nausea or abdominal distress; (8) feeling dizzy, unsteady, lightheaded, or faint; (9) derealization (feelings of unreality) or depersonalization (being detached from oneself); (10) fear of losing control; (11) fear of dying; (12) paresthesias (numbness or tingling sensations); (13) chills or hot flushes.The longer-term efficacy of alprazolam extended-release tablets USP has not been systematically evaluated. This formulation utilizes a tablet, extended release delivery system. Marketed by Proficient Rx Lp, this product is identified by NDC 63187-518 and is authorized under FDA application ANDA090871.
Identification & Billing
- RxCUI: 433798 - ALPRAZolam 0.5 MG 24HR Extended Release Oral Tablet
- RxCUI: 433798 - 24 HR alprazolam 0.5 MG Extended Release Oral Tablet
- RxCUI: 433798 - alprazolam 0.5 MG 24 HR Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63187 - Proficient Rx Lp
- 63187-518 - Alprazolam
- 63187-518-90 - 90 TABLET, EXTENDED RELEASE in 1 BOTTLE
- 63187-518 - Alprazolam
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63187-518). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63187-518-90 identifies a specific commercial package of 90 tablet, extended release in 1 bottle of Alprazolam, a human prescription drug labeled by Proficient Rx Lp. This tablet, extended release is formulated for oral use and contains alprazolam as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Proficient Rx Lp on June 07, 2011. The current certification is valid through December 31, 2027.
How is this Proficient Rx Lp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63187051890. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.